First case of symmetric drug-related intertriginous and flexural exanthema (SDRIFE) due to rivastigmine?

American Journal of Clinical Dermatology

Volumn 12, Issue 3, 2011, Pages 210-213

  Allain Veyrac, Gwenaëlle ^a   Lebreton, Anne ^a   Collonnier, Catherine ^b   Jolliet, Pascale ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Dermatologist ^*  (France)

Author keywords

Acetylcholinesterase inhibitors; adverse reactions; Contact dermatitis; drug induced; Exanthema; Rivastigmine

Indexed keywords

ALLOPURINOL; ALPRAZOLAM; HYDROCORTISONE BUTYRATE; LEUPRORELIN; LORATADINE; LORAZEPAM; MACROGOL 4000; NICERGOLINE; NIFEDIPINE; RIVASTIGMINE; ZOLPIDEM;

AGED; ARTICLE; CASE REPORT; DEMENTIA; DRUG WITHDRAWAL; ERYTHEMA; HUMAN; INTERTRIGINOUS AND FLEXURAL EXANTHEMA; MACULOPAPULAR RASH; MALE; PRIORITY JOURNAL; PRURITUS; RASH; SKIN DEFECT; SKIN EXAMINATION;

AGED, 80 AND OVER; BUTTOCKS; CHOLINESTERASE INHIBITORS; DEMENTIA; DERMATITIS, ALLERGIC CONTACT; DRUG ERUPTIONS; EXANTHEMA; HUMANS; INTERTRIGO; MALE; PHENYLCARBAMATES; SYNDROME;

EID: 79953771330     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11318350-000000000-00000     Document Type: Article

References (28)

1. Andersen KE, Hjorth N, Menné T. The baboon syndrome: systemicallyinduced allergic contact dermatitis. Contact Dermatitis 1984; 10: 97-100 (Pubitemid 14188566)
2. Sánchez-Morillas L, Reañ oMartosM, Rodríguez Mosquera M, et al. Baboon syndrome. Allergol Immunopathol (Madr) 2004; 32: 43-5
3. Häusermann P,Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 2004; 51: 297-310 (Pubitemid 40037057)
4. Helmbold P, Hegemann B, Dickert C, et al. Symmetric ptychotropic and nonpigmenting fixed drug eruption due to cimetidine (so-called baboon syndrome). Dermatology 1998; 197: 402-3 (Pubitemid 29000805)
5. Barbaud A, Tréchot P, Granel F, et al. A baboon syndrome induced by intravenous human immunoglobulins: report of a case and immunological analysis. Dermatology 1999; 199: 258-60
6. Chowdhury MM, Patel GK, Inaloz HS, et al. Hydroxyurea-induced skin disease mimicking the baboon syndrome. Clin Exp Dermatol 1999; 24: 336-7 (Pubitemid 29366920)
7. Audicana M, Bernedo N, Gonzalez I, et al. An unusual case of baboon syndrome due to mercury present in a homeopathic medicine [letter]. Contact Dermatitis 2001; 45: 185 (Pubitemid 32800382)
8. Loze I, Milpied-Homsi B, Parent E, et al. The baboon syndrome, a particular cutaneous drug eruption: four case reports [in French]. Nouvelles Dermatologiques 2001; 20: 624-5 (Pubitemid 34003238)
9. Monastero R, Lopez G, Mannino M, et al. Erythematous maculopapular eruption due to rivastigmine therapy. Am J Med 2001; 111: 583-4 (Pubitemid 33052364)
10. Schmutz JL, Barbaud A, Tréchot P. Baboon syndrome: frontline new for the backside (letter) [in French]. Ann Dermatol Venereol 2001; 128: 1378 (Pubitemid 34094144)
11. Isaksson M, Ljunggren B. Systemic contact dermatitis from ethylenediamine in an aminophylline preparation presenting as the baboon syndrome. Acta Derm Venereol 2003; 83: 69-70 (Pubitemid 36223066)
12. Gallo R, Parodi A. Baboon syndrome from 5-aminosalicylic acid [letter]. Contact Dermatitis 2002; 46: 110 (Pubitemid 34275821)
13. Amichai B, Grunwald MH. Baboon syndrome following oral roxithromycin [letter]. Clin Exp Dermatol 2002; 27: 523 (Pubitemid 35278950)
14. Sánchez-Morillas L, Reañ oMartos M, Rodríguez MosqueraM, et al. Baboon syndrome due to pseudoephedrine [letter]. Contact Dermatitis 2003; 48: 234 (Pubitemid 36776040)
15. Wolf R, Orion E, Matz H. The baboon syndrome or intertriginous drug eruption: a report of eleven cases and a second look at its parthomechanism. Dermatol Online J 2003; 9: 2
16. Moreno-Ramírez D, García-Bravo B, Rodríguez Pichardo A, et al. Baboon syndrome in childhood: easy to avoid, easy to diagnose, but the problem continues. Pediatr Dermatol 2004; 21: 250-3 (Pubitemid 38738295)
17. Jankowska-Konsur A, Kolodziej T, Szipietowski J, et al. The baboon syndrome: report of two first cases in Poland. Contact Dermatitis 2005; 52: 289-90 (Pubitemid 40756574)
18. Armingaud P, Martin L, Wierzbicka E, et al. Baboon syndrome due to a polysensitization with corticosteroids [in French]. Ann Dermatol Venereol 2005; 132: 675-7 (Pubitemid 41330194)
19. Dhingra A, Grover C. Baboon syndrome [letter]. Indian Pediatr 2007; 44: 934
20. Arnold AW, Häusermann P, Bach S, et al. Recurrent flexural exanthema (SDRIFE or baboon syndrome) after administration of two different lodinated radio contrast media. Dermatology 2007; 214: 89-93 (Pubitemid 46033008)
21. Garcia-Menaya JM, Cordobés-Duran C, Bobadilla P, et al. Baboon syndrome: 2 simultaneous cases in the same family. Contact Dermatitis 2008; 58: 108-9
22. Handisurya A, Stingl G, Wöhrl S. SDRIFE (baboon syndrome) induced by penicillin. Clin Exp Dermatol 2009; 34: 355-7
23. Barbaud A. Global management of cutaneous adverse drug reactions [in French]. Ann Dermatol Venereol 2007; 134: 391-401
24. Häusermann P, Bircher AJ. SDRIFE: another acronym for a distinct cutaneous drug exanthema: do we really need it? Dermatology 2007; 214: 1-2 (Pubitemid 46032991)
25. Bryant CA, Ouldred E, Jackson SH, et al. Purpuric rash with donazepil treatment. BMJ 1998; 317: 787
26. Herfs H, Schirren CG, Przybilla B, et al. Baboon syndrome: a particular manifestation of hematogenous contact reaction [in German]. Hautarzt 1993; 44: 466-9
27. Weiss JM,MockenhauptM, Schopf E, et al. Reproducible drug exanthema to terbinafine with characteristic distribution of baboon syndrome [in German]. Hautarzt 2001; 52: 1104-6
28. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45 (Pubitemid 12149145)